alexa
Reach Us +1(850)754-6199
Pharmacokinetic And Antigenic Properties Of Aspergillus Flavipes (JF831014) L-methioninase In Vivo | 4891
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Pharmacokinetic and antigenic properties of Aspergillus flavipes (JF831014) L-methioninase in vivo

3rd World Congress on Biotechnology

Ashraf El-Sayed

AcceptedAbstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.S1.021

Abstract
Methionine starvation can powerfully modulate DNA methylation, cell cycle transition, polyamines and antioxidant synthesis of tumor cells, in contrary to normal cells. Aspergillus flavipes L-methioninase (Af-METase) displayed affordable biochemical properties comparing to Pseudomonas putida enzyme (ONCASE) as described by our previous studies. The catalytic properties of Af-METase in New Zealand rabbits were evaluated, in vivo. Af-METase (40.8 U/ml) have T1/2 19.8 hr, elimination constant 0.088 U/hr and apparent volume of distribution 85 U/ml. In vivo, Af-METase has two maxima one at A280nm (apo-enzyme) and at A420nm (internal Schiff base with PLP), unlike control plasma (without enzyme), as baseline. The two peaks of absorption spectra were detected maximally at 15 min then the absorbance at 420nm was subsequently decreased with circulation time, due to dissociation of the co-enzyme. The A280/420 ratio was increased from 1.69 to 5.81 with circulation time from 15 to 30 hr. Plasma methionine of rabbits was depleted from 18.7 μM (control) to 8.8 μM after 1hr of enzyme injection. After 2 hr till 19 hr, L-methionine was not detected by HPLC column, assuming the sustainability of negligible levels of methionine (< 2μM) in plasma of rabbits, for about 17 hr. Upon infusion of PLP, the T1/2 of Af-METase was significantly prolonged by 3.2 fold, assuming the fully reconstitution of the enzyme. The holo-enzyme form still retained its co-enzyme, completely, till 33hr of PLP infusion. From spectral studies, the internal aldimine linkage by apo-Af-METase was formed upon infusion of PLP, with fully catalytic structure after less than 4 hr of PLP infusion, the ratio of A280/420 being not relatively changed till 45 hr. Immunologically, the titer of IgG was appeared after 25 days of last enzyme dose, by about 1.66 fold higher comparing to control (without enzyme). However, IgM was not detected along the tested challenge points. Plasma anti-Af-METase neutralizing antibodies (NAb) were assessed. No significant reduction on activity of Af-METase, only about 15 % of its initial activity was lost upon 40.8 U/ml, in vitro. All the hematological parameters were in normal range, except the titer of RBCs and level of platelet were shown to be slightly increased, after 25 days of Af-METase injection, comparing to control. There is no obvious negative effect on chemistry of liver, kidney, glucose, lipids, and other electrolytes.
Biography
Ashraf El-Sayed has completed his Ph. D in 2008 from Faculty of Science, Zagazig University, Egypt. I have postdoctoral studies in Applied Biology Department, Kyoto Institute of Technology, Japan (2008- 2009), focusing on production of gamma glutamyl dimmers as thermostable analogues to the corresponding amino acids that are valuable in food industries. Currently I am associate professor of biotechnology, faculty of science, Zagazig University. My current research concerned with biochemical, molecular characterization, immobilization and posttranslational modifications of some therapeutic enzymes as L-methioninase, cystathionine gamma lyase, homocysteine gamma lyase, arginase, arginine deiminase and L-amino acid oxidase. I have published more than 12 in reputed journals. I am reviewer for more than 30 published paper various reputed journals.
Top